PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$114.24
Tradestie Score
60
Market Cap
$699.30M
Analyst Upside
+100.5%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.32
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.05
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.09
|
$1.78B | - | 47 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.29
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.82
|
$1.74B | - | 59 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.34
|
$1.68B | - | 54 | Compare |
|
MNKD
Mannkind Corporation
|
$3.09
|
$1.65B | - | 57 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$33.09
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$8.76
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$33.03
|
$1.56B | 77.0 | 58 | Compare |
More PVLA Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry